HopeStage
Back to all studies
CompletedNCT03689543

Estrogen Receptor Beta and Mood During Perimenopause

About this titleRead the official source — NCT03689543
Medication studyAges 45–65United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 45 years to 65 years.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 23, 2019
Recruitment status
Completed
Enrollment listed in the registry
74
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 45 Years to 65 Years
Official registry ID
NCT03689543
Official title
Show the full official title

The Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-withdrawal-induced Mood Symptoms in Women With Past Perimenopausal Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Estradiol, ER Beta Agonist and Provera.

Who was this study for?

Listed age limits: 45 years to 65 years.

Want to explore more studies?

Explore studies